Director Shizuru Judith Anne made two open market purchases of Jasper Therapeutics ($JSPR) shares in the past year, totaling $99,630. Her most recent buy occurred on September 22, 2025. Among nearly 5,000 insiders, her activity ranks 2,342nd by purchase value, well below the average of $1.5 million over about 3.3 transactions. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 22, 2025 | Jasper Therapeutics, Inc. | $JSPR | Shizuru Judith Anne | Director | P | Voting Common Stock | 41000 | $2.43 | 156,901.0000 | 15,333,962 | 35.38% | 0.27% |
| Sept. 22, 2025 | Jasper Therapeutics, Inc. | $JSPR | Shizuru Judith Anne | Director | P | Common Stock Warrant (right to buy) | 41000 | $0.00 | 41,000.0000 | 15,333,962 | 9999.99% | 0.27% |
| July 3, 2025 | Jasper Therapeutics, Inc. | $JSPR | Shizuru Judith Anne | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 15,333,962 | 9999.99% | 0.05% |
| June 6, 2024 | Jasper Therapeutics, Inc. | $JSPR | Shizuru Judith Anne | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 13,334,900 | 9999.99% | 0.06% |